Cargando…
Loss of chance associated with sub-optimal HPV vaccination coverage rate in France
INTRODUCTION: Since 2007, HPV vaccination programs have been implemented in Europe. Significant real-life impact has already been reported in countries where the programs have been successfully implemented. In France, HPV vaccination coverage rate (VCR) is currently one of the lowest in Europe. This...
Autores principales: | Uhart, Mathieu, Adam, Marjorie, Dahlab, André, Bresse, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883194/ https://www.ncbi.nlm.nih.gov/pubmed/28720460 http://dx.doi.org/10.1016/j.pvr.2017.02.004 |
Ejemplares similares
-
Epidemiological and economic burden of potentially HPV-related cancers in France
por: Abramowitz, Laurent, et al.
Publicado: (2018) -
Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France
por: de Rycke, Yann, et al.
Publicado: (2020) -
A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France
por: Bresse, Xavier, et al.
Publicado: (2013) -
Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
por: Riethmuller, Didier, et al.
Publicado: (2015) -
Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe
por: Marty, Rémi, et al.
Publicado: (2013)